{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:08Z","timestamp":1707524168314},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,30]]},"DOI":"10.7759\/cureus.11255","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T12:30:54Z","timestamp":1604061054000},"source":"Crossref","is-referenced-by-count":0,"title":["Chronic Disease Management in Sickle Cell Trait Patients in the Primary Care Setting: A Case Report"],"prefix":"10.7759","author":[{"given":"Rachel N","family":"Fields","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Minor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.11","article-title":"Sickle cell disease","volume":"4","year":"2018","unstructured":"Sickle cell disease. Nat Rev Dis Primers. 2018, 4.18011. 10.1038\/nrdp.2018.11","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000446526","article-title":"Sickle cell trait: a benign state?","volume":"136","author":"Kotila TR","year":"2016","unstructured":"Kotila TR. Sickle cell trait: a benign state?. Acta Haematologica. 2016, 136:147-151. 10.1159\/000446526","journal-title":"Acta Haematologica"},{"key":"ref3","unstructured":"National Athletic Trainers\u2019 Association. Consensus statement. sickle cell trait and the athlete. https:\/\/www.nata.org\/sites\/default\/files\/sickle-cell-trait-and-the-athlete.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16326.1","article-title":"Case report: exertional rhabdomyolysis in a spin class participant with sickle cell trait","volume":"7","author":"Longo T","year":"2018","unstructured":"Longo T, Shaines M. Case report: exertional rhabdomyolysis in a spin class participant with sickle cell trait. F1000. 2018, 7:1742. 10.12688\/f1000research.16326.1","journal-title":"F1000"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2014.1034","article-title":"The splenic syndrome in individuals with sickle cell trait","volume":"15","author":"Goodman J","year":"2014","unstructured":"Goodman J, Hassell K, Irwin D, Witkowski EH, Nuss R. The splenic syndrome in individuals with sickle cell trait. High Alt Med Biol. 2014, 15:468-471. 10.1089\/ham.2014.1034","journal-title":"High Alt Med Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.160","article-title":"Sickle cell trait diagnosis: clinical and social implications","volume":"2015","author":"Naik RP","year":"2015","unstructured":"Naik RP, Haywood C. Sickle cell trait diagnosis: clinical and social implications. Hematology. 2015, 2015:160-167. 10.1182\/asheducation-2015.1.160","journal-title":"Hematology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27492013000500016","article-title":"Sickle cell retinopathy: diagnosis and treatment","volume":"76","author":"Bonanomi MT","year":"2013","unstructured":"Bonanomi MT, Lavezzo MM. Sickle cell retinopathy: diagnosis and treatment. Arq Bras Oftalmol. 2013, 76:320-327. 10.1590\/s0004-27492013000500016","journal-title":"Arq Bras Oftalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1179\/1607845415y.0000000024","article-title":"Splenic infarction associated with sickle cell trait at low altitude","volume":"20","author":"Seegars MB","year":"2015","unstructured":"Seegars MB, Brett AS. Splenic infarction associated with sickle cell trait at low altitude. Hematology. 2015, 20:607-609. 10.1179\/1607845415y.0000000024","journal-title":"Hematology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0699","article-title":"Sickle cell trait worsens oxidative stress, abnormal blood rheology, and vascular dysfunction in type 2 diabetes","volume":"38","author":"Diaw M","year":"2015","unstructured":"Diaw M, Pialoux V, Martin C, et al.. Sickle cell trait worsens oxidative stress, abnormal blood rheology, and vascular dysfunction in type 2 diabetes. Diabetes Care. 2015, 38:2120-2127. 10.2337\/dc15-0699","journal-title":"Diabetes Care"},{"key":"ref10","article-title":"Identifying factors underlying the decision for sickle cell carrier screening among African Americans within middle reproductive age","volume":"27","author":"Mayo-Gamble TL","year":"2018","unstructured":"Mayo-Gamble TL, Middlestadt SE, Lin H, Cunningham-Erves J, Barnes P, Jackson PB. Identifying factors underlying the decision for sickle cell carrier screening among African Americans within middle reproductive age. J Genet Couns. 2018, 27:1302-1311.","journal-title":"J Genet Couns"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)61493-6","article-title":"Post-splenectomy and hyposplenic states","volume":"378","author":"Sabatino AD","year":"2011","unstructured":"Sabatino AD, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet. 2011, 378:86-97. 10.1016\/s0140-6736(10)61493-6","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(18)30033-0","article-title":"Sickle-cell trait and diagnosis of type 2 diabetes","volume":"6","author":"Skinner S","year":"2018","unstructured":"Skinner S, Pialoux V, Fromy B, Sigaudo-Roussel D, Connes P. Sickle-cell trait and diagnosis of type 2 diabetes. Lancet Diabetes Endocrinol. 2018, 6:840-843. 10.1016\/s2213-8587(18)30033-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.20994","article-title":"Sickle cell trait and interpretation of hemoglobin A1c levels","volume":"317","author":"Bleyer AJ","year":"2017","unstructured":"Bleyer AJ, Aloi JA. Sickle cell trait and interpretation of hemoglobin A1c levels. JAMA. 2017, 317:481. 10.1001\/jama.2016.20994","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212552","article-title":"Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait","volume":"14","author":"Skinner S","year":"2019","unstructured":"Skinner S, Diaw M, Mbaye MN, et al.. Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait. PLoS One. 2019, 14:212552. 10.1371\/journal.pone.0212552","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v8.i3.108","article-title":"Acute and chronic hepatobiliary manifestations of sickle cell disease: a review","volume":"8","author":"Shah R","year":"2017","unstructured":"Shah R, Taborda C, Chawla S. Acute and chronic hepatobiliary manifestations of sickle cell disease: a review. World J Gastrointest Pathophysiol. 2017, 8:108-116. 10.4291\/wjgp.v8.i3.108","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.25592","article-title":"Renal medullary carcinoma and sickle cell trait: a systematic review","volume":"62","author":"Alvarez O","year":"2015","unstructured":"Alvarez O, Rodriguez MM, Jordan L, Sarnaik S. Renal medullary carcinoma and sickle cell trait: a systematic review. Pediatr Blood Cancer. 2015, 62:1694-1699.","journal-title":"Pediatr Blood Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.046","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 14: sickle cell trait: a scientific statement from the American Heart Association and American College of Cardiology","volume":"66","author":"Maron BJ","year":"2015","unstructured":"Maron BJ, Harris KM, Thompson PD, Eichner R, Steinberg MH. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 14: sickle cell trait: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015, 66:2444-2446. 10.1016\/j.jacc.2015.09.046","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.418","article-title":"Balancing exercise risk and benefits: lessons learned from sickle cell trait and sickle cell anemia","volume":"2018","author":"Liem RI","year":"2018","unstructured":"Liem RI. Balancing exercise risk and benefits: lessons learned from sickle cell trait and sickle cell anemia. Hematology. 2018, 2018:418-425. 10.1182\/asheducation-2018.1.418","journal-title":"Hematology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/34423-chronic-disease-management-in-sickle-cell-trait-patients-in-the-primary-care-setting-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:18Z","timestamp":1707506358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/34423-chronic-disease-management-in-sickle-cell-trait-patients-in-the-primary-care-setting-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.11255","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,30]]}}}